Latest news

Clinical

BMS Reports Twin Phase 3 Wins in Lung Disease And Solid Tumor

Bristol Myers Squibb (BMS) has announced positive Phase 3 results for two investigational therapies targeting different diseases. The company reported...
Research & Development

Argenx Scraps Phase III Sjögren Study Over Predicted Efficacy Failure

Argenx has stopped a Phase 3 study testing its marketed therapy Vyvgart Hytrulo in Sjögren’s disease after an interim...
Commercial

Roche Signs Huge Deal With Rona, Joins ALK7 Obesity Race

Roche has agreed to pay Rona Therapeutics up to $100 million in upfront and short-term milestone payments to secure...
Insights

Top 10 AI Trends Reshaping Precision Medicine

Executive Summary Precision medicine is moving from a largely genomics-driven model toward a broader approach that combines molecular, clinical, imaging,...
Insights

The Economics of Decentralized Clinical Trials

Executive Summary Decentralized clinical trials are changing how pharmaceutical companies...
Insights

Top 10 Digital Biomarkers Changing Clinical Research

Executive Summary Clinical research is expanding beyond measurements collected during...
Commercial

Theramex purchases Asieris’ innovative cervical lesion treatment for up to $250 million

Asieris, a China-based company, has agreed to pay up to $250 million to get the first-in-class, non-surgical treatment for...
Clinical

MimiVax’s brain cancer vaccine misses phase 2b goal, but CEO sees a path forward in younger patients

MimiVax’s cancer vaccine failed to meet the primary endpoint in a phase 2b trial in newly diagnosed glioblastoma, but...
Clinical

Cerevance’s Solengepras Meets Phase 3 Goal in Parkinson’s Disease Trial

Cerevance reported positive topline results from its Phase 3 ARISE trial, showing that its oral investigational therapy solengepras reduced...
Regulatory

FDA Identifies Four Deaths in Newron’s Evenamide Studies as Clinical Hold Continues

Newron Pharmaceuticals said the U.S. Food and Drug Administration...
Clinical

Zealand’s obesity medication fails once more in phase 3

Boehringer Ingelheim's survodutide drug has achieved the co-primary endpoints...
Manufacturing

BD Plans Huge U.S. Investment to Expand Medical Manufacturing

BD is preparing a major expansion of its U.S. operations, adding to a growing list of healthcare companies increasing...
Clinical

Phase 3 Firmonertinib Study Misses Primary Endpoint in EGFR Exon 20 NSCLC

ArriVent BioPharma reported that its phase 3 Furvent trial of firmonertinib in previously untreated patients with non-squamous locally advanced...
Insights

How Healthcare Organizations Are Building AI Centers of Excellence

   Executive Summary Artificial intelligence is moving from isolated healthcare experiments toward broader organizational adoption. Hospitals, health systems, pharmaceutical companies, insurers, and...
Commercial

Life Sciences Voice In Collaboration With Future Pharma EU 2026

Future Pharma Europe returns on 20–21 October 2026 in...
Editorial Team -
Commercial

Roche Signs Huge Deal With Rona, Joins ALK7 Obesity Race

Roche has agreed to pay Rona Therapeutics up to...
Editorial Team -
Commercial

Vogenx Files for a Nasdaq Capital Market IPO to Fund Metabolic Drug

Vogenx is preparing to enter the public markets by...
Commercial

$15 Million Investment to Compete in the Eczema Challenge alongside Amgen and Sanofi

Ichnos Sciences has, at last, found a potential buyer...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Regulatory

Regulatory

FDA Identifies Four Deaths in Newron’s Evenamide Studies as Clinical Hold Continues

Newron Pharmaceuticals said the U.S. Food and Drug Administration...
Editorial Team -
Research & Development

Argenx Scraps Phase III Sjögren Study Over Predicted Efficacy Failure

Argenx has stopped a Phase 3 study testing its...
Commercial

Roche Signs Huge Deal With Rona, Joins ALK7 Obesity Race

Roche has agreed to pay Rona Therapeutics up to...
Insights

Top 10 AI Trends Reshaping Precision Medicine

Executive Summary Precision medicine is moving from a largely genomics-driven...
Insights

The Economics of Rare Disease Drug Development

Executive Summary Rare disease drug development presents a distinctive economic...

Research & Development

Market Access

Manufacturing

Genentech signs a $490 million breast cancer partnership and lays off 103 employees with gRED Rethink

The Roche subsidiary has just announced that the restructuring...
Manufacturing

fda selects seven drugmakers for precheck pilot to accelerate u.s. manufacturing reviews

The U.S. Food and Drug Administration (FDA) has selected...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Clinical

BMS Reports Twin Phase 3 Wins in Lung Disease And Solid Tumor

Bristol Myers Squibb (BMS) has announced positive Phase 3...
Editorial Team -
Commercial

Roche Signs Huge Deal With Rona, Joins ALK7 Obesity Race

Roche has agreed to pay Rona Therapeutics up to...
Editorial Team -